← FDA Drug Approvals (Drugs@FDA)

AMLODIPINE AND OLMESARTAN MEDOXOMIL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2017-05-15

Drug application

FDA Application #

ANDA206906

Application type

Abbreviated New Drug Application (Generic)

Brand name

AMLODIPINE AND OLMESARTAN MEDOXOMIL

Generic name

AMLODIPINE AND OLMESARTAN MEDOXOMIL

Active ingredients

AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

AUROBINDO PHARMA

Manufacturer

Aurobindo Pharma Limited

First approval

2017-05-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown